BCL2 and ovarian serous adenocarcinoma: Similarly, a study on serous ovarian cancer cell lines demonstrated that PIK3R1 downregulation induced the expression of antiapoptotic BCL2, as well as genes involved in cell cycle progression (CCNB1) and metastasis (MMP9 and VEGFA) [23].